Drugs@FDA document
MANNITOL 5% Letter · NDA 016269 SUPPL-56
Drugs@FDA document · HOSPIRA · Mar 19, 2020
Key facts
| Drug name | MANNITOL 5% |
|---|---|
| Document type | Letter |
| Application | NDA016269 |
| Submission | SUPPL-56 |
| Company | HOSPIRA |
| Document date | Mar 19, 2020 |
| FDA document | accessdata.fda.gov |
At a glance
- Efficacy-Labeling Change With Clinical Data, Labeling-Package Insert Document categories
- 1–9 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: